SCHEMBL21836819

SCHEMBL21836819

CCC(=O)N1CCC2(CC1)CC2c1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.46
▸ KDM1A O60341 1/20 0.41
▸ RCOR1 Q9UKL0 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ CXCR3 P49682 1/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LIG1 P18858 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ NAMPT P43490 2/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RORC P51449 1/20 0.37
▸ BTK Q06187 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21836858 0.90 NAMPT (0.44) EPHX2KDM1ARCOR1OPRM1NPC1
SCHEMBL21836834 0.85 KDM1A (0.47) KDM1ARCOR1LIG1HPGDALDH1A1
SCHEMBL21837058 0.83 LIG1 (0.42) KDM1ARCOR1LIG1HPGDBLM
SCHEMBL21836883 0.83 LIG1 (0.42) KDM1ARCOR1LIG1HPGDBLM
SCHEMBL21836906 0.83 LIG1 (0.42) KDM1ARCOR1LIG1HPGDBLM
SCHEMBL21836772 0.82 GPR183 (0.43) SMN1; SMN2LIG1HPGDNAMPTALDH1A1
SCHEMBL21942003 0.78 RORC (0.55) NAMPTRORC
SCHEMBL21942437 0.78 RORC (0.55) NAMPTRORC
SCHEMBL21836852 0.78 RORC (0.55) NAMPTRORC
SCHEMBL21836870 0.77 GPR183 (0.47) LIG1ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315565-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FORMA THERAPEUTICS, INC. 2022-10-06 — — US disclosed
US-11299484-B2 Inhibiting fatty acid synthase (FASN) FORMA THERAPEUTICS, INC. (US) 2022-04-12 — — US disclosed
US-20210024508-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FORMA THERAPEUTICS, INC. 2021-01-28 — — US disclosed
US-10875848-B2 Inhibiting fatty acid synthase (FASN) FORMA THERAPEUTICS, INC. (US) 2020-12-29 — — US disclosed
US-20200115368-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FORMA THERAPEUTICS, INC. 2020-04-16 — — US disclosed
EP-3636637-A1 INHIBITING FATTY ACID SYNTHASE (FASN) Forma Therapeutics, Inc. (US) 2020-04-15 — — EP disclosed
EP-3636637-A1 INHIBITING FATTY ACID SYNTHASE (FASN) Forma Therapeutics, Inc. (US) 2020-04-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10875848-B2 Inhibiting fatty acid synthase (FASN) FASN, SCD, FADS1 EPHX2 1734/4885KDM1A 4064/4885RCOR1 1698/4885
US-20210024508-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FASN, SCD, FADS1 EPHX2 1734/4885KDM1A 4064/4885RCOR1 1698/4885
US-20200115368-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FASN, SCD, FADS1 EPHX2 1734/4885KDM1A 4064/4885RCOR1 1698/4885
US-20220315565-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FASN, SCD, FADS1 EPHX2 1734/4885KDM1A 4064/4885RCOR1 1698/4885
US-11299484-B2 Inhibiting fatty acid synthase (FASN) FASN, SCD, FADS1 EPHX2 1734/4885KDM1A 4064/4885RCOR1 1698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback